• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Where's the real info like old times

Anonymous

Guest
Back in recent times, there used to be some real intelligence on what was going on at Merck posted on cafe pharma. Now it's trolls deflecting the topic on each thread.
Is this the overall corporation's effort to squash any type of employee opinion that doesn't tow the company line? Caution - do not be naive enough to install Merck's software to your smartphone. It can and will be used against you.